It may be niche, but it's a big niche in a data-driven world.

In combination with atezolizumab, ZEPZELCA has been approved for use in Australia and Singapore as a maintenance treatment for extensive-stage small cell lung cancer (ES-SCLC) in adult patients whose ...

The new clinical research will be presented by Dr. John C. Lantis II. The real-world trial found that intact fish-skin demonstrated superior clinical effectiveness when compared with standard care for ...

With shortages of medical professionals and an aging population, thousands of community health care workers prevent older ...

Valo Health, Inc. ("Valo"), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment of Chris Anagnostopoulos, PhD, C.Stat, to the newly ...

Background Neutrophils guarantee a prompt and robust host response to pathogens. Yet, overshooting neutrophil activation ...

Patients with RAS G12D non-small cell lung cancer remain a population with a significant unmet medical need for targeted therapeutic options,” said Jonathan Riess M.D., medical director of thoracic ...

In this article, we outline actionable strategies for strengthening one of the most essential administrative data ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data from two ...

Most people assume high-paying jobs come with high stress. New research reveals 10 careers that offer six-figure salaries and ...

House File 2513, which targets the use of H-1B visas in higher education, has already passed the Iowa House and cleared ...